A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.

Neiveyans, Madeline

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. [electronic resource] - mAbs 04 2019 - 593-605 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1942-0870

10.1080/19420862.2018.1564510 doi


Animals
Antibody-Dependent Cell Cytotoxicity
Antigens, CD--immunology
Antineoplastic Agents, Immunological--immunology
CHO Cells
Cricetulus
HEK293 Cells
Humans
Leukemia, Erythroblastic, Acute--drug therapy
Lymphoma, B-Cell--drug therapy
Mice
Mice, Knockout
Receptors, Transferrin--immunology
Single-Chain Antibodies--immunology